Anandamide

Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.

Cross Reference

Introduction

To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Anandamide?

Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Anandamide

MeSH term MeSH ID Detail
Stomach Ulcer D013276 75 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Pain D010146 64 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Per page 10 20 50 100 | Total 105

PubChem Associated disorders and diseases

What pathways are associated with Anandamide

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Anandamide?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Anandamide?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Anandamide?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Anandamide?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Anandamide?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Anandamide

Download all related citations
Per page 10 20 50 100 | Total 2222
Authors Title Published Journal PubMed Link
Kaplan BL et al. Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide. 2005 Toxicol. Appl. Pharmacol. pmid:15893538
van der Stelt M et al. A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. 2005 FASEB J. pmid:15894565
Vandevoorde S and Fowler CJ Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate. 2005 Br. J. Pharmacol. pmid:15895107
Hillard CJ and Jarrahian A Accumulation of anandamide: evidence for cellular diversity. 2005 Neuropharmacology pmid:15910883
Jia Y et al. TRPV1 receptor: a target for the treatment of pain, cough, airway disease and urinary incontinence. 2005 Drug News Perspect. pmid:15915217
Ahern GP et al. Extracellular cations sensitize and gate capsaicin receptor TRPV1 modulating pain signaling. 2005 J. Neurosci. pmid:15917451
Glass M et al. Misidentification of prostamides as prostaglandins. 2005 J. Lipid Res. pmid:15863842
Osei-Hyiaman D et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. 2005 J. Clin. Invest. pmid:15864349
Siegmund SV et al. Anandamide induces necrosis in primary hepatic stellate cells. 2005 Hepatology pmid:15841466
Ortega-Gutiérrez S et al. Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures. 2005 Glia pmid:15920730
Bari M et al. Cholesterol-dependent modulation of type 1 cannabinoid receptors in nerve cells. 2005 J. Neurosci. Res. pmid:15920744
Gavva NR et al. AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. 2005 J. Pharmacol. Exp. Ther. pmid:15615864
Sancho R et al. Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine. 2005 J. Immunol. pmid:16148147
Ho WS and Hillard CJ Modulators of endocannabinoid enzymic hydrolysis and membrane transport. 2005 Handb Exp Pharmacol pmid:16596775
Kraft B and Kress HG Indirect CB2 receptor and mediator-dependent stimulation of human whole-blood neutrophils by exogenous and endogenous cannabinoids. 2005 J. Pharmacol. Exp. Ther. pmid:16055676
Poblete IM et al. Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed. 2005 J. Physiol. (Lond.) pmid:16081483
Mishima K et al. Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. 2005 Stroke pmid:15845890
Justinova Z et al. The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys. 2005 J. Neurosci. pmid:15944392
Maccarrone M et al. Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction. 2005 J. Cell. Sci. pmid:16144868
Randall MD The cardiovascular actions of anandamide: more targets? 2005 Br. J. Pharmacol. pmid:15834438
Yang W et al. Enzymatic formation of prostamide F2alpha from anandamide involves a newly identified intermediate metabolite, prostamide H2. 2005 J. Lipid Res. pmid:16150817
Kwolek G et al. Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats. 2005 Br. J. Pharmacol. pmid:15834445
Gasperi V et al. Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells. 2005 Neurotoxicology pmid:16154199
Mestre L et al. Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis. 2005 J. Neurochem. pmid:15748152
Sun YX et al. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. 2005 Biochim. Biophys. Acta pmid:16154384
Domenicali M et al. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. 2005 Gut pmid:15753538
Barun S et al. Effects of cannabinoid receptor activation on rabbit bisected vas deferens strips. 2005 Clin. Exp. Pharmacol. Physiol. pmid:16173925
Bazinet RP et al. Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain. 2005 Neurochem. Res. pmid:16176062
Oz M et al. Effects of saturated long-chain N-acylethanolamines on voltage-dependent Ca2+ fluxes in rabbit T-tubule membranes. 2005 Arch. Biochem. Biophys. pmid:15639235
Straiker A and Mackie K Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. 2005 J. Physiol. (Lond.) pmid:16179366
Engeli S et al. Activation of the peripheral endocannabinoid system in human obesity. 2005 Diabetes pmid:16186383
Underdown NJ et al. Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. 2005 Br. J. Pharmacol. pmid:16158067
Maccarrone M et al. Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility. 2005 Mol. Hum. Reprod. pmid:15563449
Mechoulam R Plant cannabinoids: a neglected pharmacological treasure trove. 2005 Br. J. Pharmacol. pmid:16205721
Wang Y et al. VR1-mediated depressor effects during high-salt intake: role of anandamide. 2005 Hypertension pmid:16144988
Patel S et al. The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity. 2005 J. Lipid Res. pmid:15576840
Fegley D et al. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. 2005 J. Pharmacol. Exp. Ther. pmid:15579492
Lee MG et al. Effect of olvanil and anandamide on vagal C-fiber subtypes in guinea pig lung. 2005 Br. J. Pharmacol. pmid:16056239
Movahed P et al. Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation. 2005 Br. J. Pharmacol. pmid:15997233
Movahed P et al. Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists. 2005 J. Biol. Chem. pmid:16081411
Awumey EM et al. Is there a role for anandamide in cardiovascular regulation? Insights from studies of endocannabinoid metabolism. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:16014613
Solbrig MV et al. A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena. 2005 Exp. Neurol. pmid:16022863
Gaskari SA et al. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. 2005 Br. J. Pharmacol. pmid:16025138
Kurabayashi M et al. 2-Arachidonoylglycerol increases in ischemia-reperfusion injury of the rat liver. 2005 Jan-Feb J Invest Surg pmid:15804949
Basavarajappa BS and Hungund BL Role of the endocannabinoid system in the development of tolerance to alcohol. 2005 Jan-Feb Alcohol Alcohol. pmid:15550443
Rodríguez de Fonseca F et al. The endocannabinoid system: physiology and pharmacology. 2005 Jan-Feb Alcohol Alcohol. pmid:15550444
Abalo R et al. Evaluation of the effect of age on cannabinoid receptor functionality and expression in guinea-pig ileum longitudinal muscle-myenteric plexus preparations. 2005 Jul 22-29 Neurosci. Lett. pmid:15936532
Glaser ST et al. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide. 2005 Nov-Dec Vis. Neurosci. pmid:16469181
Millns PJ et al. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors. 2006 Eur. J. Neurosci. pmid:17229097
Matias I et al. Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. 2006 Int J Obes (Lond) pmid:16570107
Schiano Moriello A et al. Development of the first potential covalent inhibitors of anandamide cellular uptake. 2006 J. Med. Chem. pmid:16570928
Appendino G et al. Oxyhomologues of anandamide and related endolipids: chemoselective synthesis and biological activity. 2006 J. Med. Chem. pmid:16570929
Chang L et al. Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms. 2006 Br. J. Pharmacol. pmid:16501580
Fezza F et al. Methods to assay anandamide hydrolysis and transport in synaptosomes. 2006 Methods Mol. Med. pmid:16506407
Kaczocha M et al. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase. 2006 J. Biol. Chem. pmid:16461355
Waku K [Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol]. 2006 Yakugaku Zasshi pmid:16462096
Petersen G et al. Intestinal levels of anandamide and oleoylethanolamide in food-deprived rats are regulated through their precursors. 2006 Biochim. Biophys. Acta pmid:16478679
Guindon J et al. Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain. 2006 Pain pmid:16480822
Busch L et al. Effects of castration on cannabinoid cb receptor expression and on the biological actions of cannabinoid in the parotid gland. 2006 Clin. Exp. Pharmacol. Physiol. pmid:16487271
Schelling G et al. Effects of general anesthesia on anandamide blood levels in humans. 2006 Anesthesiology pmid:16436846
Guindon J and Beaulieu P Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain. 2006 Neuropharmacology pmid:16442133
Bermúdez-Siva FJ et al. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. 2006 Eur. J. Pharmacol. pmid:16423347
Prestifilippo JP et al. Inhibition of salivary secretion by activation of cannabinoid receptors. 2006 Exp. Biol. Med. (Maywood) pmid:16946411
Spoto B et al. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol. 2006 Biochimie pmid:16949718
Vlachou S et al. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward. 2006 Psychopharmacology (Berl.) pmid:16953388
Mulder AM and Cravatt BF Endocannabinoid metabolism in the absence of fatty acid amide hydrolase (FAAH): discovery of phosphorylcholine derivatives of N-acyl ethanolamines. 2006 Biochemistry pmid:16981687
Hong Z et al. Role of store-operated calcium channels and calcium sensitization in normoxic contraction of the ductus arteriosus. 2006 Circulation pmid:16982938
Stefano GB and Salamon EJ Nitric oxide and anandamide in OMT research. 2006 J Am Osteopath Assoc pmid:17122026
Lambert RC et al. Modulation of neuronal T-type calcium channels. 2006 CNS Neurol Disord Drug Targets pmid:17168746
Di Marzo M et al. Synthesis, conformational analysis and CB1 binding affinity of hairpin-like anandamide pseudopeptide mimetics. 2006 J. Pept. Sci. pmid:16534762
Cobellis G et al. Endocannabinoid system in frog and rodent testis: type-1 cannabinoid receptor and fatty acid amide hydrolase activity in male germ cells. 2006 Biol. Reprod. pmid:16611862
Solinas M et al. Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats. 2006 J. Neurochem. pmid:16805835
Vinod KY et al. Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system. 2006 Neurochem. Int. pmid:16822589
Ghasemi M et al. Effect of anandamide on nonadrenergic noncholinergic-mediated relaxation of rat corpus cavernosum. 2006 Eur. J. Pharmacol. pmid:16824514
Wagner JA et al. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts. 2006 J. Cardiovasc. Pharmacol. pmid:16775503
Bonechi C et al. Nuclear magnetic resonance for studying recognition processes between anandamide and cannabinoid receptors. 2006 Eur J Med Chem pmid:16837109
Costa B et al. AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain. 2006 Br. J. Pharmacol. pmid:16770320
Felder CC et al. Cannabinoids biology: the search for new therapeutic targets. 2006 Mol. Interv. pmid:16809476
Yeh JH et al. Effect of anandamide on cytosolic Ca(2+) levels and proliferation in canine renal tubular cells. 2006 Basic Clin. Pharmacol. Toxicol. pmid:16623868
Laviolette SR and Grace AA The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction. 2006 Cell. Mol. Life Sci. pmid:16699809
Balas L et al. Synthesis of a potential photoactivatable anandamide analog. 2006 Bioorg. Med. Chem. Lett. pmid:16682198
Shouman B et al. Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage. 2006 Br. J. Pharmacol. pmid:16682966
Zaniewska M et al. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats. 2006 Eur. J. Pharmacol. pmid:16730696
Li J and Wang DH Differential mechanisms mediating depressor and diuretic effects of anandamide. 2006 J. Hypertens. pmid:17053550
Krishtal O et al. The agonists for nociceptors are ubiquitous, but the modulators are specific: P2X receptors in the sensory neurons are modulated by cannabinoids. 2006 Pflugers Arch. pmid:16741755
Wang Y et al. A novel scintillation proximity assay for fatty acid amide hydrolase compatible with inhibitor screening. 2006 Anal. Biochem. pmid:16707086
Schmidt A et al. Determination of the endocannabinoid anandamide in human plasma by high-performance liquid chromatography. 2006 Biomed. Chromatogr. pmid:16189813
Bai X et al. TASK channel expression in human placenta and cytotrophoblast cells. 2006 J. Soc. Gynecol. Investig. pmid:16378911
Hejazi N et al. Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. 2006 Mol. Pharmacol. pmid:16332990
Bojesen IN and Hansen HS Effect of an unstirred layer on the membrane permeability of anandamide. 2006 J. Lipid Res. pmid:16365480
Dembiński A et al. Cannabinoids in acute gastric damage and pancreatitis. 2006 J. Physiol. Pharmacol. pmid:17218765
D'Argenio G et al. Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. 2006 FASEB J. pmid:16403786
Nakajima Y et al. Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition. 2006 FEBS Lett. pmid:16406050
Suplita RL et al. Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. 2006 Neuropharmacology pmid:16316669
Avelino A and Cruz F TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications. 2006 Naunyn Schmiedebergs Arch. Pharmacol. pmid:16721555
Murillo-Rodriguez E et al. Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat. 2006 Life Sci. pmid:16434061
Ligresti A et al. New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis. 2006 Br. J. Pharmacol. pmid:16284631
Bir LS and Ercan S Effects of intrathecal anandamide on somatosensory evoked responses in rats. 2006 Exp. Neurol. pmid:16289169
Urbani P et al. New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies. 2006 Bioorg. Med. Chem. Lett. pmid:16213718
Malfitano AM et al. Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis. 2006 J. Neuroimmunol. pmid:16239036